Pressure Infusers and Associated Products

Tender description

An NHS Supply Chain, non-exclusive Framework Agreement for the supply to NHS Supply Chain depots via the Stock and Blue Diamond routes and to the NHS Supply Chain customer base via the E-Direct Route. This Framework Agreement is for the supply of Pressure Infusers and Associated Products, including: • Disposable Single Patient Use Pressure Infusers • Reusable Pressure Infusers It is anticipated that in the first 24 months of the Framework Agreement the value of purchases will be circa £1,800,000. The figures for the full 48 months term (if extended) is circa £3,600,000. These values are approximate only and are based on the most recent historical usage information. The values provided are for guidance only and are not a guarantee of business. Lot Lot 1: Disposable Single Patient Use Pressure Infusers Pressure infusers are used for the infusion of paternal intravenous fluids This Lot includes disposable single patient use pressure infusers. NHS Supply Chain anticipates appointing all Applicants who meet the minimum requirements which are set out in these tender documents and whose total score meets or exceeds a hurdle of 35% at tender evaluation stage to the relevant line of the Framework Agreement. NHS Supply Chain will only trade with the highest scoring two Applicants for each Product Line except in the instance where a supply issue arises, for the initial 24 months of the Framework Agreement. Lot Lot 2: Reusable Pressure Infusers Pressure infusers are used for the infusion of paternal intravenous fluids This Lot includes reusable pressure infusers. NHS Supply Chain anticipates appointing all Applicants who meet the minimum requirements which are set out in these tender documents and whose total score meets or exceeds a hurdle of 35% at tender evaluation stage to the relevant line of the Framework Agreement. NHS Supply Chain will only trade with the highest scoring single Applicant for each Product Line except in the instance where a supply issue arises, for the initial 24 months of the Framework Agreement.